Skip to content

keyhole limpet hemocyanin

BIOLOGICAL15 trials

Sponsors

Oncothyreon Canada Inc., Memorial Sloan Kettering Cancer Center, University of Nebraska, Intracel, Genitope Corporation

Conditions

Bladder CancerBreast CancerGerm Cell TumorHealthy Adult VolunteersHealthy VolunteersKidney CancerLeukemiaLung Cancer

Phase 1

Phase 2

Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma
TerminatedNCT00006478
University of NebraskaLymphoma
Start: 2000-10-11End: 2008-04-03Updated: 2023-09-18
Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy
CompletedNCT00004249
Memorial Sloan Kettering Cancer CenterLung Cancer
Start: 1998-08-31End: 2001-11-30Updated: 2013-06-19
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma
CompletedNCT00004198
University of NebraskaLymphoma
Start: 1999-06-25End: 2003-11-20Updated: 2023-12-27
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
CompletedNCT00004197
University of NebraskaLymphoma
Start: 1999-06-25End: 2003-11-20Updated: 2023-09-07
Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
NCT00093522
St. Luke's Medical CenterKidney Cancer
Start: 2004-08-31Target: 28Updated: 2013-12-19
A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
CompletedNCT00282308
Genentech, Inc.Rheumatoid Arthritis
Start: 2006-01-23End: 2012-05-28Updated: 2017-08-10
Vaccine Therapy in Treating Patients With Multiple Myeloma
CompletedNCT00019097
National Cancer Institute (NCI)Refractory Plasma Cell Neoplasm, Stage III Multiple Myeloma, Stage II Multiple Myeloma
Start: 1995-07-31End: 2007-03-31Updated: 2024-03-04

Phase 3

Related Papers